Skip to main content
Poly Medicure Ltd logo

Poly Medicure Ltd — Investor Relations & Filings

Ticker · POLYMED ISIN · INE205C01021 LEI · 335800XM9YRKFWFVXO61 BSE.NS Manufacturing
Open in API
Filings indexed 1,060 across all filing types
Latest filing 2023-05-25 Regulatory Filings
Country IN India
Listing BSE.NS POLYMED

About Poly Medicure Ltd

https://www.polymedicure.com

Poly Medicure Ltd, known as Polymed, is a global medical device company specializing in the design, development, and manufacture of high-quality medical consumables and equipment. The company offers a comprehensive portfolio of over 160 products across various clinical segments, including infusion therapy, oncology, anesthesia, urology, gastroenterology, blood management, and dialysis. Key offerings include IV cannulas, central venous catheters, blood collection systems, and respiratory care devices. With a strong emphasis on research and development, the company operates multiple state-of-the-art manufacturing facilities and maintains international quality certifications. Polymed serves a diverse global market, providing cost-effective and innovative healthcare solutions to hospitals and medical professionals worldwide.

Recent filings

Filing Released Lang Actions
Dear Sir/Madam, Pursuant to Regulation 24(a) of SEBI (LODR) Regulations, 2015, We enclose herewith Annual Secretarial Compliance Report of the Company for the financial year ended 31st ....
Regulatory Filings
2023-05-25 English
Updates
Regulatory Filings Classification · 95% confidence The document text is extremely short (112 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document cannot be classified as a report or announcement. It fits best as a Regulatory Filing (RNS) fallback category due to absence of any other identifiable filing type.
2023-05-09 English
In Compliance of Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, We hereby declare that M/ s. M.C. Bhandari & Company, Statutory Auditors of the Company have issued Audit Report with ....
Regulatory Filings
2023-05-09 English
Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosures ....
Regulatory Filings
2023-05-09 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is titled 'Declaration of related party transactions for year ended 31st March, 2023' and contains detailed disclosures of transactions between the company and related parties, including remuneration, sales, purchases, leases, and dividends. It includes financial figures and descriptions of the nature of transactions during the reporting period. This type of detailed related party transaction disclosure is typically part of regulatory compliance filings but is not a full annual report or audit report. It is a specific disclosure related to related party transactions, which is often filed as a Regulatory Filing (RNS) in the absence of a more specific category. The document is about related party transactions and does not fit categories like Annual Report, Audit Report, or Management Reports. It is not a short announcement but a detailed disclosure. Therefore, the best fit is Regulatory Filings (RNS).
2023-05-09 English
Financial Result Updates
Regulatory Filings
2023-05-09 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.